Specialty pharmaceuticals and urology treatments by UroGen Pharma

  • Ivan Andriyenko
  • 04.11.2026
UroGen Pharma announces third quarter 2026 financial results: Can URGN break above $34.94?
UroGen Pharma is scheduled to report its third quarter 2026 financial results. The stock is little changed on the day, trading near $34.4.UroGen Pharma announced it will report its third quarter ...
  • Anastasiia Chabaniuk
  • 02.11.2026
UroGen Pharma begins Phase 1 treatment in NMIBC: Will URGN hold $32.4 support?
UroGen Pharma announced that its first patient has started treatment in a Phase 1 study of UGN-501 for non-muscle invasive bladder cancer. The stock is down 2.2% on the day at $32.72.UroGen Pharma ...
  • Ciaran Ryan
  • 28.10.2026
UroGen Pharma announces live webcast for Q3 2026 results after muted trading session
UroGen Pharma said it will report third quarter 2026 financial results in a live webcast on November 4. The stock edges lower on the day, trading at $33.91.UroGen Pharma plans to release its third ...
  • Andrey Mastykin
  • 05.08.2026
UroGen Pharma stock gains 3.45 percent to $39.92 as bullish momentum continues
UroGen Pharma will report its Q2 2026 financial results and host a live earnings call at 10:00 AM ET today. At the same time, UroGen Pharma stock is up 3.4% on the day at $39.92.UroGen Pharma ...
  • Jose Antonio Gastelum
  • 05.08.2026
UroGen Pharma stock gains 3.45 percent to $39.92 as buyers defend gap-up momentum
UroGen Pharma said it will report its Q2 2026 financial results and host a live earnings call today at 10:00 AM ET. At the same time, UroGen Pharma stock is up 3.4% on the day at $39.92.The ...
  • Ezequiel Gomes
  • 29.07.2026
UroGen Pharma stock trades down 1.40% ahead of Q2 earnings webcast, UroGenPharma announces
UroGen Pharma will report its second quarter 2026 financial results during a live webcast on Wednesday, August 5 at 10:00 AM ET.The company provided this update on social media. The stock trades ...
  • Ezequiel Gomes
  • 29.07.2026
UroGen Pharma stock holds at $40.88 as UroGenPharma announces Q2 webcast date
UroGen Pharma will report its second quarter 2026 financial results during a live webcast on Wednesday, August 5 at 10:00 AM ET.Details on how to access the webcast are available in the company's ...
  • Ciaran Ryan
  • 27.07.2026
UroGen Pharma ticks up to $41.34 as company joins 2026 BCAN Bladder Cancer Think Tank
UroGen Pharma will participate in BCAN’s 2026 Bladder Cancer Think Tank in Denver, Colorado.UroGen Pharma said it looks forward to joining urologists, oncologists, researchers, patient ...
  • Dan Blystone
  • 27.07.2026
UroGen Pharma edges higher to $41.34 as it announces participation in BCAN 2026 Think Tank
UroGen Pharma is joining urologists, oncologists, researchers, patient advocates, and industry leaders for discussions at BCAN’s 2026 Bladder Cancer Think Tank in Denver, Colorado.The company ...
  • Ciaran Ryan
  • 23.07.2026
UroGen Pharma stock consolidates below 52-week high as bullish trend persists
UroGen Pharma announced that its Chairman, Arie Belldegrun, MD, will participate in a Fireside Chat on Thursday, July 23, from 12:00-12:30 PM ET in Boston, MA.The session will take place at ...
  • Jainam Mehta
  • 23.07.2026
UroGen Pharma stock trades up to $42.13 as UroGen Pharma promotes kidney cancer fireside chat
UroGen Pharma said Chairman Arie Belldegrun, MD, will participate in a Fireside Chat on Thursday, July 23, from 12:00-12:30 PM ET in Boston, MA.He will join the session titled 'Innovation, ...
  • Sholanke Dele
  • 29.06.2026
UroGen Pharma stock consolidates below 52-week high amid sustained bullish momentum
UroGen Pharma states that Jason, with experience in healthcare, pharmaceutical, and corporate law, plays a key role in guiding the company through regulatory changes.UroGen Pharma says Jason ...
  • Ciaran Ryan
  • 29.06.2026
UroGen Pharma stock consolidates below 52-week high amid sustained bullish momentum
UroGen Pharma states that Jason, with experience in healthcare, pharmaceutical, and corporate law, plays a key role in guiding the company through regulatory changes.UroGen Pharma says Jason ...
  • Ciaran Ryan
  • 29.06.2026
UroGen Pharma edges higher to $34.88 as leadership highlights integrity focus, UroGen Pharma
UroGen Pharma said Jason guides the company through an evolving regulatory landscape and helps foster a culture of integrity and accountability.The company noted Jason's deep experience in ...
  • Ezequiel Gomes
  • 08.06.2026
UroGen Pharma stock consolidates near weekly lows with mild gains after conference event update
UroGen Pharma will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami Beach on June 10.The event will take place from 8:40 to 9:15 AM ET. UroGen ...
  • Jainam Mehta
  • 08.06.2026
UroGen Pharma edges higher to $27.07 ahead of Goldman Sachs healthcare chat, UroGen Pharma
UroGen Pharma will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami Beach. The event is scheduled for June 10 from 8:40 to 9:15 AM Eastern ...